MEK inhibitors for the treatment of NRAS mutant melanoma

Saro Sarkisian,1 Diwakar Davar2 1Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA; 2Division of Hematology-Oncology, Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA, USA Abstract: Melanoma is increasing rapidly in incidence and prevalence, esp...

Full description

Bibliographic Details
Main Authors: Sarkisian S, Davar D
Format: Article
Language:English
Published: Dove Medical Press 2018-08-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/mek-inhibitors-for-the-treatment-of-nras-mutant-melanoma-peer-reviewed-article-DDDT